跳至主要内容
临床试验/NCT02144818
NCT02144818Unknown不适用

GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
The main outcome is the number of mature oocytes

研究概览

简要总结

During the last decades, owing to the growing tendency of women to delay childbearing plans because of career and personal priorities, fertility specialists today are seeing more and more women with poor ovarian reserve and with poor ovarian response Controlled ovarian hyperstimulation (COH) is considered a important factor in the success of in vitro fertilization-embryo transfer (IVF-ET), enabling the recruitment of multiple oocytes and, thereby, resulting in more than one embryo. However, owing to the extreme variability in ovarian response to COH, in a subgroup of patients with poor ovarian response, this method may yield a very small number of follicles After succeeding in maximal recruitment of the follicles, the triggering of ovulation is extremely important in order to achieve, as many as, mature oocytes.

Several studies have reported retrieval of more mature oocytes after GnRH agonist triggering compared to the number of oocytes retrieved after hCG. Among the possible advantages of GnRH agonist for final oocyte maturation is the simultaneous induction of an FSH surge. The role of the natural mid-cycle FSH surge is not fully clear. FSH was reported to induce LH receptor formation in luteinizing granulosa cells, and to promote oocyte nuclear maturation and cumulus expansion .

Another method described to trigger ovulation is the "Dual triggering"- GnRH agonist 40 h prior to ovum pickup and hCG added 6 h after the first trigger. The dual triggering was described as the treatment in cases with recurrent empty follicles.

The aim of the present study is to evaluate three different methods of ovulation triggering in women with poor ovarian response

详细描述

Inclusion criteria:

  • Women with low ovarian response according to the Bologna criteria, undergoing IVF treatments for this cause.

Exclusion criteria:

  • Women with good ovarian response.
  • Women with low ovarian response who are carriers of fragile X

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with low ovarian response according to the Bologna criteria, undergoing IVF treatments for this cause.

排除标准

  • Women with good ovarian response.
  • Women with low ovarian response who are carriers of fragile X

研究组 & 干预措施

GnRH agonist

Active Comparator

干预措施: Decapeptyl (Drug)

hCG

Active Comparator

干预措施: Ovitrel (Drug)

dual triggering: GnRH agonist and hCG

Active Comparator

干预措施: Ovitrel (Drug)

dual triggering: GnRH agonist and hCG

Active Comparator

干预措施: Decapeptyl (Drug)

结局指标

主要结局

The main outcome is the number of mature oocytes

时间窗: up to 12 months

number of embryos appropriate for transfer

时间窗: up to 12 month

次要结局

  • pregnancy rate(up to 12 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Jigal Haas MD

Senior Gynecologist and Obstetrician

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验